Concerns over JN.1 Variant Rise as India Records 640 New COVID-19 Cases; "SMCH is prepared," Dr. Bhaskar Gupta

India, on Friday, reported a concerning uptick in COVID-19 infections, with 640 fresh cases recorded, pushing the total number of active cases to 2,997 from the previous day’s 2,669, according to data from the Union Health Ministry.

The surge in cases has been linked to the emergence of the JN.1 variant of the Coronavirus. On Tuesday, the World Health Organization (WHO) classified the JN.1 coronavirus strain as a “variant of interest” and stated that current evidence suggests a low risk to public health from this particular strain.

Responding to the escalating situation, the Central Government of India has issued an advisory, urging states to intensify surveillance efforts. The Health Minister has conducted several meetings, emphasizing that while there is no immediate cause for panic, the government is proactively enhancing preparations to address any potential surge.

Silchar Medical College and Hospital (SMCH), serving as the primary government healthcare and testing facility for Southern Assam’s population of over four million, stands ready to confront the emerging challenges. Dr. Bhaskar Gupta, the Principal of SMCH, assured Barak Bulletin in an interview that the hospital has been providing healthcare services since the detection of the first COVID-19 case in Assam. He stated, “We are closely monitoring the current situation and will respond accordingly. SMCH is well-equipped with doctors, paramedics, nurses, and beds with ventilation and oxygen supply. We will allocate resources based on the number of cases reporting to the hospital.”

Addressing the testing facilities, Dr. Debdatta Dhar, Professor and in charge of COVID testing at SMCH, affirmed that the testing facility is fully operational and prepared for any significant surge. “Historically, we have observed an increase in cases in Silchar and Assam approximately one month after similar rises are reported in Maharashtra and Kerala. Now we will wait and observe how the situation unfolds in this region,” added Professor Dhar.

To better understand the situation, the central authorities have recommended genome sequencing of samples to determine the presence of the new variant in the region. Genome sequencing, usually performed in NIV Pune, involves transporting samples over a considerable distance, risking changes in their chemical composition. However, Professor Dhar revealed that SMCH has signed an MOU with a specialized vendor for sample transportation, ensuring the samples reach NIV Pune in optimal condition.

While the situation is being closely monitored, neither the medical professionals nor the government has sounded alarm bells. The unfolding events over the next 30 days will determine the trajectory of the COVID-19 situation in the region.